Reactive airway disease is a habit...

Reactive airway disease is a habitual reason for emergency department visits and hospital admissions in infants and young children. The treatment for reactive airway disease is bronchodilating agents, usually delivered through a nebulizer. This system of delivery can be precious and time consuming. Recent studies have prompted that, compared with nebulizers, bronchodilators delivered by means of a metered-dose inhaler with a spacer may provide the same, if not better, consequence s in children and adults. Studies have examined the use of metered-dose inhalers with spacers in children with reactive airway disease, further there have been no well-designed studies in children brace years and younger. Delgado and colleagues compared the administration of albuterol through a metered-dose inhaler with a spacer device versus a nebulizer in the treatment of wheezing in children brace years and younger.

The double-blind, randomized, placebo-controlled research examined a convenient sample of children pair to 24 months of age who neared to an emergency department with wheezing. The participants were randomly assigned to receive either active treatment with albuterol in a metered-dose inhaler followed according to a placebo nebulizer treatment, or placebo metered-dose inhaler treatment followed by dint of albuterol delivered by a nebulizer. The metered-dose inhaler had a spacer device with a mask that was held onward the child's face during the administration of the appeases Treatments were repeated every 20 minutes. The consequence measures, which included admission rate, oxygen saturation, and Pulmonary Index score, were evaluated 10 minutes after each treatment. The Pulmonary Index score is a validated asthma severity score that includes four measures scored from cipher to 3. In this studious mood mild asthma had a Pulmonary Index score of naught to 3, moderate asthma had a score of 4 to 7 and chaste asthma had a score of 8 to 12

During the initial assessment, the children who received albuterol through nebulizer had a significantly higher Pulmonary Index score than the children using metered-dose inhalers with spacers. When data were controll for severity of asthma, children who received albuterol on metered-dose inhalers with spacers had fewer admissions than children in the nebulizer cluster In addition, the group using metered-dose inhalers with spacers were significantly les likely to receive additional treatments or steroids, and had a lower mean increase in heart rate. There were no significant differences between the collections when comparing the percentage of improvement of Pulmonary Index score, final oxygen saturation, or percentage of patients who vomited.

The authors decide that albuterol delivered by a metered-dose inhaler with a spacer device may be as effective as nebulizer delivery in children brace years and younger who are wheezing. They add that metered-dose inhalers with spacer devices provide physicians with an easier and efficient rule of delivering albuterol to infants and younger children.

Delgado A, et al. Nebulizers v metered-dose inhalers with spacers for bronchodilator therapy to treat wheezing in children aged 2 to 24 month in a pediatric pinch department. Arch Pediatr Adolesc M January 2003; 157:76-80

COPYRIGHT 2003 American Academy of Family Physicians

COPYRIGHT 2003 Gale Group